Showing 39,381 - 39,386 results of 39,386 for search '(( significant decrease decrease ) OR ( significant ((level disease) OR (teer decrease)) ))', query time: 0.75s Refine Results
  1. 39381

    Extraction time and mustard concentration for extraction of aquatic oligochaetes by using wet funnel by Satoshi Kaneda (571209)

    Published 2025
    “…Statistical calculations were performed in R version 4.2.2 (R Development Core Team, 2022), and the significance of the explanatory variable was assessed with F-tests using package car. …”
  2. 39382

    Table 1_Prediction of apolipoprotein A-I and high-density lipoprotein cholesterol in the neurological impairment and relapse of neuromyelitis optica spectrum disorder.docx by Yanyan Wang (329749)

    Published 2025
    “…</p>Conclusion<p>Reduced levels of ApoA-I and HDL-C were associated with more severe neurological deficits and an increased risk of relapse.…”
  3. 39383

    C2CD3 regulates spatial organization of centriole architecture. by Eloïse Bertiaux (5309927)

    Published 2025
    “…<b>(C)</b> SAS6 length is significantly reduced in siC2CD3 (<i>n</i> = 28, 68 ± 25 nm) vs. siCTRL (<i>n</i> = 45, 104 ± 36 nm), ****<i>P</i> < 0.0001. …”
  4. 39384

    A Proposal for Implementation of Multi-Factor Authentication (MFA) System for Enhanced Security By Stephen Mikah Makoshi by Stephen Mikah Makoshi (20998469)

    Published 2025
    “…<b>Reduced Reliance on Passwords</b>: Decreased risk of security incidents related to passwords.…”
  5. 39385

    C2CD3 is crucial for the localization of the LDR and DISCO complexes. by Eloïse Bertiaux (5309927)

    Published 2025
    “…Centriole diameter was not significantly altered (siCTRL: <i>n</i> = 44, 115 ± 24 nm; siC2CD3: <i>n</i> = 44, 123 ± 27 nm; <i>P</i> = 0.0564). …”
  6. 39386

    LRIG1 and CDK6 expression in the lateral ventricular wall cells by Hyung-song Nam (8914220)

    Published 2025
    “…Although the <i>Cdk6</i> mRNA decreases significantly in the neuroblasts, the DCX+ neuroblasts still show a lot of td-sfGFP immunoreactivity.…”